News
Press Release | September 8, 2021
Immunitas Therapeutics Appoints Seng-Lai ‘Thomas’ Tan, Ph.D. as Chief Scientific Officer
Press Release | August 18, 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
News | July 13, 2021
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells
News | June 1, 2021
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases
News | May 18, 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Press Release | March 31, 2021
Entrada Therapeutics Announces Closing of $116 Million Series B Financing
Press Release | March 30, 2021
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
Press Release | March 18, 2021
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
News | January 8, 2021
DiCE gets its ‘library’ card ready as it speeds development of DNA database-derived molecules with more investor cash
News | January 7, 2021
CARISMA Therapeutics Completes Series B Funding to Advance Development of Novel CAR-Macrophage Immunotherapies
1
2